Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

por Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Publicado 2009

1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management

por Lièvre, A., Turpin, A., Ray-Coquard, I.L., Le Malicot, K., Thariat, J., Ahle, G., Mathieu, R., Sebbagh, V., Debieuvre, D., Canellas, A., Garcia-Larnicol, M-L., Colle, R., Hardy-Bessard, A-C., Mansi, L., Bourhis, J., Gorphe, P., Ursu, R., IDBAIH Ahmed, A., Zalcman, G., Bouche, O.
Publicado 2020